Announcements

Posted: 2022-06-28

Welcome to the Chinese edition of Precision Cancer Medicine

We are glad to share with you that select PCM content is now available in Chinese

Posted: 2022-01-17

PCM Annual Report 2021

We are glad to present a brief report on the progress of Precision Cancer Medicine (PCM) in 2021

Posted: 2021-11-05

Precision Cancer Medicine (PCM) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Precision Cancer Medicine (PCM) is among the list of COPE membership.

Posted: 2021-07-02

Precision Cancer Medicine (PCM) is indexed in Scopus

On June 26, 2021, we received the good news from Elsevier that Precision Cancer Medicine (PCM) has been accepted for inclusion in Scopus.

Posted: 2021-01-15

PCM Annual Report 2020

As we prepare this brief 2020 annual report of Precision Cancer Medicine (PCM), the world is still in the fight against COVID-19 pandemic that has gravely impacted every aspects of our personal and professional lives for over a year.

Posted: 2020-04-29

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.

Posted: 2020-03-19

Implementation of transparent peer review at Precision Cancer Medicine (PCM)

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to implement a transparent peer review process as an option for all manuscripts submitted to PCM from March 19, 2020.

Posted: 2020-01-10

PCM Annual Report (2019)

PCM Annual Report (2019)

Posted: 2019-10-15

Application of the CARE Guideline as reporting standard in Precision Cancer Medicine

Precision Cancer Medicine welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.

Posted: 2019-01-10

PCM Annual Report (2018)

PCM Annual Report (2018)

Posted: 2018-09-11

Call for Papers - Focused Issue: Genomic Instability, Clonal Evolution and Oncogenesis

Call for Papers - Focused Issue: Genomic Instability, Clonal Evolution and Oncogenesis

1 - 11 of 11 Items